Trending: play_arrow pause

play_arrow pause

$AYTU Multiple insights in the last few minutes:

1. ๐Ÿ“œ SEC Form 424B5 filed by Aytu BioScience, Inc.
2. ๐Ÿ“œ SEC Form 424B3 filed by Aytu BioScience, Inc.

#majorpharmaceuticals #healthcare

$AYTU ๐Ÿ“œ Aytu BioScience, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

#majorpharmaceuticals #healthcare

$HARP ๐Ÿ“ƒ Harpoon Therapeutics Provides Progress Update for TriTACยฎ Clinical Programs and ProTriTACโ„ข Platform


$HARP ๐Ÿ“œ SEC Form 4: GADICKE ANSBERT sold $1,186,190 worth of Common Stock (57,494 units at $20.63)


$BIIB ๐Ÿ“ฐ Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemraยฎ (Tocilizumab)


$ZYNE ๐Ÿ“ฐ Zynerba Pharmaceuticals Announces Acceptance of Poster at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

#majorpharmaceuticals #healthcare

$UNH ๐Ÿ“ฐ United Health Foundation Launches $3 Million Partnership with CAMBA, Inc. to Improve Access to Prenatal Care for Brooklyn's Most Vulnerable Residents

#medicalspecialities #healthcare

$BYSI ๐Ÿ“ฐ BeyondSpring Presents Phase 1 Data on the Anti-Cancer Effect of Plinabulin in Combination with Checkpoint Inhibitors in SCLC at the American Society of Clinical Oncology (ASCO) Annual Meeting

#healthcare #majorpharmaceuticals

Nothing found!

Sorry, but we could not find anything in our database for your search query {{search_query}}. Please try again by typing other keywords.